Literature DB >> 27546733

Effect of acute hyperinsulinemia on magnesium homeostasis in humans.

Li Hao Richie Xu1, Naim M Maalouf1,2,3.   

Abstract

BACKGROUND: Insulin may influence magnesium homeostasis through multiple mechanisms. Acutely, it stimulates the shift of magnesium from plasma into red blood cells and platelets, and in vitro, it stimulates the activity of the TRPM6 channel, a key regulator of renal magnesium reabsorption. We investigated the impact of hyperinsulinemia on magnesium handling in participants with a wide range of insulin sensitivity.
METHOD: Forty-seven participants were recruited, including 34 nondiabetic controls and 13 with type 2 diabetes mellitus. After stabilization under fixed metabolic diet, participants underwent hyperinsulinemic-euglycemic clamp. Serum and urine samples were collected before and during hyperinsulinemia. Change in serum magnesium, urinary magnesium to creatinine (Mg2+ :Cr) ratio, fractional excretion of urinary magnesium (FEMg2+ ), and estimated transcellular shift of magnesium were compared before and during hyperinsulinemia.
RESULTS: Hyperinsulinemia led to a small but statistically significant decrease in serum magnesium, and to a shift of magnesium into the intracellular compartment. Hyperinsulinemia did not significantly alter urinary magnesium to creatinine ratio or fractional excretion of urinary magnesium in the overall population, although a small but statistically significant decline in these parameters occurred in participants with diabetes. There was no significant correlation between change in fractional excretion of urinary magnesium and body mass index or insulin sensitivity measured as glucose disposal rate.
CONCLUSIONS: In human participants, acute hyperinsulinemia stimulates the shift of magnesium into cells with minimal alteration in renal magnesium reabsorption, except in diabetic patients who experienced a small decline in fractional excretion of urinary magnesium. The magnitude of magnesium shift into the intracellular compartment in response to insulin does not correlate with that of insulin-stimulated glucose entry into cells.
Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  TRPM6; hyperinsulinemia; magnesium

Mesh:

Substances:

Year:  2016        PMID: 27546733     DOI: 10.1002/dmrr.2844

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  6 in total

Review 1.  Hypomagnesemia in the Cancer Patient.

Authors:  Biruh T Workeneh; Nupur N Uppal; Kenar D Jhaveri; Helbert Rondon-Berrios
Journal:  Kidney360       Date:  2020-11-11

Review 2.  Magnesium and Human Health: Perspectives and Research Directions.

Authors:  Abdullah M Al Alawi; Sandawana William Majoni; Henrik Falhammar
Journal:  Int J Endocrinol       Date:  2018-04-16       Impact factor: 3.257

Review 3.  Mineral and Electrolyte Disorders With SGLT2i Therapy.

Authors:  Giuseppe Cianciolo; Antonio De Pascalis; Irene Capelli; Lorenzo Gasperoni; Luca Di Lullo; Antonio Bellasi; Gaetano La Manna
Journal:  JBMR Plus       Date:  2019-11-04

Review 4.  The Extraglycemic Effect of SGLT-2is on Mineral and Bone Metabolism and Bone Fracture.

Authors:  Bingzi Dong; Ruolin Lv; Jun Wang; Lin Che; Zhongchao Wang; Zhouyang Huai; Yangang Wang; Lili Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-07       Impact factor: 6.055

5.  Canagliflozin, serum magnesium and cardiovascular outcomes-Analysis from the CANVAS Program.

Authors:  Katherine M Wang; JingWei Li; Vivek Bhalla; Meg J Jardine; Bruce Neal; Dick de Zeeuw; Greg Fulcher; Vlado Perkovic; Kenneth W Mahaffey; Tara I Chang
Journal:  Endocrinol Diabetes Metab       Date:  2021-03-13

6.  SGLT2 Inhibitors for Treatment of Refractory Hypomagnesemia: A Case Report of 3 Patients.

Authors:  Evan C Ray; Cary R Boyd-Shiwarski; Pengfei Liu; Danica Novacic; David Cassiman
Journal:  Kidney Med       Date:  2020-04-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.